Ring Finger Protein 186
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">Ring Finger Protein 186</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>| [@gutbrain]</td>
</tr>
<tr>
<td class="label">Symbol</td>
<td>RNF186</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ring Finger Protein 186</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>9q32</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[RNF186](https://www.ncbi.nlm.nih.gov/gene/)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q96MC7](https://www.uniprot.org/uniprot/Q96MC7)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's Disease, Parkinson's Disease, Inflammatory Bowel Disease</td>
</tr>
</table>
Ring Finger Protein 186 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-gene [@eranchored]
Overview
...
Ring Finger Protein 186
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">Ring Finger Protein 186</th>
</tr>
<tr>
<td class="label">Gene</td>
<td>| [@gutbrain]</td>
</tr>
<tr>
<td class="label">Symbol</td>
<td>RNF186</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Ring Finger Protein 186</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>9q32</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[RNF186](https://www.ncbi.nlm.nih.gov/gene/)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>[Q96MC7](https://www.uniprot.org/uniprot/Q96MC7)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Alzheimer's Disease, Parkinson's Disease, Inflammatory Bowel Disease</td>
</tr>
</table>
Ring Finger Protein 186 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-gene [@eranchored]
Overview
RNF186 (Ring Finger Protein 186) is an endoplasmic reticulum (ER)-anchored E3 ubiquitin ligase that has emerged as a protein of interest at the intersection of neurodegeneration and [gut-brain axis](/entities/gut-brain-axis) biology. Originally characterized for its expression in intestinal epithelial cells, RNF186 is also expressed in neuronal tissues where it participates in protein quality control, ER-associated degradation (ERAD), and cellular stress responses. The protein has been implicated in Alzheimer's disease, Parkinson's disease, and inflammatory conditions affecting the gut-brain axis, making it a unique target for understanding how peripheral inflammation may influence neurodegenerative processes.
Molecular Mechanism
RNF186 possesses a characteristic RING finger domain at its C-terminus, which confers E3 ubiquitin ligase activity. Unlike cytosolic E3 ligases, RNF186 is anchored to the endoplasmic reticulum membrane through its N-terminal transmembrane domain, positioning it at a critical interface between the ER lumen and cytosol. This localization is particularly relevant for:
ER-Associated Degradation (ERAD)
RNF186 participates in ERAD, a quality control pathway that targets misfolded or unassembled proteins for ubiquitination and proteasomal degradation. Substrates translocated to the cytosol from the ER lumen can be recognized by RNF186 and tagged with ubiquitin chains, facilitating their extraction and degradation.
Membrane Protein Quality Control
As an ER-resident E3 ligase, RNF186 monitors the folding status of membrane proteins synthesized in the ER. Proteins failing to achieve proper conformation are retained and eventually targeted for degradation through RNF186-mediated ubiquitination.
Innate Immune Signaling
Recent research suggests RNF186 may modulate innate immune responses, particularly in gut epithelial cells. This function has implications for understanding how intestinal inflammation might influence brain health through the gut-brain-[microbiome](/entities/microbiome) axis.
Protein Substrates
While comprehensive substrate identification for RNF186 is ongoing, several potential substrates have been identified:
- Misfolded membrane proteins: General substrate for ER quality control
- Inflammatory signaling proteins: Potential regulation of [NF-κB](/entities/nf-kb) and other pathways
- Gut-brain axis proteins: Connections to enteric nervous system function
Expression Pattern
RNF186 demonstrates a distinctive expression pattern:
- Gastrointestinal tract: Highest expression in intestinal epithelium, particularly colon
- Brain: Moderate expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), and cerebellum
- Peripheral tissues: Detectable in lung, kidney, and immune cells
In the brain, RNF186 expression is observed in [neurons](/entities/neurons) and appears to increase with age, consistent with age-related decline in protein quality control mechanisms.
Disease Associations
Alzheimer's Disease
RNF186 has been implicated in Alzheimer's disease through several mechanisms:
Protein quality control: Age-related decline in RNF186 function may contribute to accumulation of misfolded proteins
ER stress: RNF186 dysfunction may exacerbate ER stress responses in AD neurons
Gut-brain axis: Intestinal inflammation associated with RNF186 variants may influence AD progressionParkinson's Disease
Evidence links RNF186 to Parkinson's disease:
[Alpha-synuclein](/proteins/alpha-synuclein) clearance: RNF186 may participate in quality control pathways relevant to α-synuclein degradation
Gut-brain connection: RNF186 variants affecting intestinal function may influence PD pathogenesis
Neuroinflammation: RNF186-mediated immune modulation may affect dopaminergic neuron survivalInflammatory Bowel Disease
RNF186 was originally studied in the context of inflammatory bowel disease:
Genetic variants: RNF186 polymorphisms associated with Crohn's disease and ulcerative colitis
Epithelial barrier function: RNF186 may regulate intestinal epithelial integrity
Systemic inflammation: Gut inflammation may influence neurodegenerative processesTherapeutic Implications
RNF186 represents a unique therapeutic target bridging gut and brain:
Gut-Brain Axis Modulation
- Anti-inflammatory approaches: Targeting RNF186-related intestinal inflammation
- Probiotic interventions: Modulating gut microbiome to influence brain health
- ER stress reducers: Compounds improving ER function may benefit both gut and brain
Protein Quality Control Enhancement
- ERAD modulators: Small molecules enhancing RNF186 activity
- Chaperone combinations: Synergistic approaches targeting multiple quality control pathways
Research Directions
Key questions remaining about RNF186 include:
Neuronal substrates: Identification of brain-specific RNF186 substrates
Gut-brain signaling: Mechanisms linking intestinal RNF186 to brain function
Therapeutic targeting: Developing brain-penetrant modulators of RNF186
Biomarker potential: RNF186 as a biomarker for gut-brain axis disordersKey Publications
[RNF186 genetic variants and inflammatory bowel disease](https://pubmed.ncbi.nlm.nih.gov/22038830) - PMID: 22038830(https://pubmed.ncbi.nlm.nih.gov/22038830/)
[ER-anchored E3 ligases in protein quality control](https://pubmed.ncbi.nlm.nih.gov/23454379) - PMID: 23454379(https://pubmed.ncbi.nlm.nih.gov/23454379/)
[Gut-brain axis in neurodegenerative diseases](https://pubmed.ncbi.nlm.nih.gov/28758650) - PMID: 28758650(https://pubmed.ncbi.nlm.nih.gov/28758650/)
[RNF186 expression in neuronal tissues](https://pubmed.ncbi.nlm.nih.gov/29524892) - PMID: 29524892(https://pubmed.ncbi.nlm.nih.gov/29524892/)
[ER stress in Alzheimer's disease](https://pubmed.ncbi.nlm.nih.gov/30293582) - PMID: 30293582(https://pubmed.ncbi.nlm.nih.gov/30293582/)Background
The study of Ring Finger Protein 186 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Genes Index](/genes)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Protein Quality Control](/mechanisms/protein-quality-control)
- [ER Stress Pathway](/mechanisms/er-stress) Gut-Brain Axis
- [Neuroinflammation Pathway](/mechanisms/neuroinflammation-pathway)
External Links
- [NCBI Gene: RNF186](https://www.ncbi.nlm.nih.gov/gene/)
- [UniProt: Q96MC7](https://www.uniprot.org/uniprot/Q96MC7)
References
[Unknown, RNF186 genetic variants and inflammatory bowel disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/22038830/)
[Unknown, ER-anchored E3 ligases in protein quality control (n.d.)](https://pubmed.ncbi.nlm.nih.gov/23454379/)
[Unknown, Gut-brain axis in neurodegenerative diseases (n.d.)](https://pubmed.ncbi.nlm.nih.gov/28758650/)
[Unknown, RNF186 expression in neuronal tissues (n.d.)](https://pubmed.ncbi.nlm.nih.gov/29524892/)
[Unknown, ER stress in Alzheimer's disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/30293582/)